Molecular pathology of the cutaneous basement membrane zone

Clinical and Experimental Dermatology

Volumn 24, Issue 1, 1999, Pages 25-32

  Mellerio, J E ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN;

BASEMENT MEMBRANE; BULLOUS SKIN DISEASE; CLINICAL FEATURE; CYTOPATHOLOGY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EPIDERMOLYSIS BULLOSA; GENE MUTATION; GENOTYPE; KERATINOCYTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

BASEMENT MEMBRANE; COLLAGEN; EPIDERMOLYSIS BULLOSA; HUMANS; MEMBRANE PROTEINS; MUTATION;

EID: 0032906290     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1999.00400.x     Document Type: Review

References (45)

1. Fine J-D, Bauer EA, Briggaman RA et al. Revised clinical and laboratory criteria for subtypes of epidermolysis bullosa: a consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991; 24: 119-35.
2. McGrath JA, Gatalica B, Christiano AM et al. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a transmembrane hemidesmosomal collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nature Genet 1995; 11: 83-6.
3. Vidal F, Aberdam D, Miquel C et al. Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nature Genet 1995; 10: 229-34.
4. Christiano AM, Uitto J. Molecular complexity of the cutaneous basement membrane zone: revelations from paradigms of epidermolysis bullosa. Exp Dermatol 1996; 5: 1-11.
5. Christiano AM, Uitto J. Molecular diagnosis of inherited skin diseases: the paradigm of dystrophic epidermolysis bullosa. Adv Dermatol 1996; 11: 199-213.
6. Corden LD, McLean WHI. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 1996; 5: 297-307.
7. Smith FJD, Eady RAJ, Leigh IM et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nature Genet 1996; 13: 450-7.
8. Pulkkinen L, Kimonis VE, Xu Y et al. Homozygous α6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 1997; 6: 669-74.
9. Eady RAJ, Tidman MJ. Diagnosing epidermolysis bullosa. Br J Dermatol 1983; 108: 621-6.
10. Fuchs E. Genetic disorders of keratins and their associated proteins. J Dermatol Sci 1996; 13: 181-92.
11. Uttam J, Hutton E, Coulombe PA et al. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci (USA) 1996; 93: 9079-84.
12. Rugg EI McLean WHI, Lane EB et al. A functional 'knockout' of human keratin 14. Genes Dev 1994; 8: 2563-73.
13. Jonkman MF, Heeres K, Pas HH et al. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 1996; 107: 764-9.
14. Corden LD, Mellerio JE, Gratian MJ et al. Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex. Hum Mutat 1998; 11: 279-85.
15. Hovnanian A, Pollack E, Hilal L et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nature Genet 1993; 3: 327-32.
16. Wiche G, Krepler R, Artlieh U et al. Occurrence and immunolocalization of plectin in tissues. J Cell Biol 1983; 97: 887-901.
17. Uitto J, Pulkkinen L, Smith FJD et al. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol 1996; 5: 237-46.
18. Pulkkinen L, Smith FJD, Shimizu H et al. Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Hum Mol Genet 1996; 5: 1539-46.
19. Schofield OMV, Fine J-D, Verrando P et al. GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol 1990; 23: 1078-83.
20. Pulkkinen L, Christiano AM, Gerecke D et al. A homozygous mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994; 24: 357-60.
21. Pulkkinen L, Christiano AM, Airenne T et al. Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nature Genet 1994; 6: 293-8.
22. McGrath JA, Kivirikko S, Ciatti S et al. A homozygous nonsense mutation in the α3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: prenatal exclusion in a fetus at risk. Genomics 1995; 29: 282-4.
23. McGrath JA, Pulkkinen L, Christiano AM et al. Altered laminin 5 expression due to mutations in the gene encoding the β3 chain (LAMB3) in generalized atrophic benign epidermolysis bullusa. J Invest Dermatol 1995; 104: 467-74.
24. McGrath JA, Christiano AM, Pulkkinen L et al. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol 1996; 106: 1157-9.
25. Darling TN, Bauer JW, Hintner H, Yancey KB. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 1998; 13: 87-119.
26. Gatalica B, Pulkkinen L, Li K et al. Cloning of the human type XVII collagen gene (COL17AI), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet 1997; 60: 352-65.
27. Mellerio JE, Eady RAJ, Atherton DJ et al. E 210K mutation in the gene encoding the β3 chain of laminin 5 (LAMB3) is predictive of a phenotype of generalized atrophic benign epidermolysis bullosa. Br J Dermatol; 1998; 139: 325-31.
28. Pulkkinen L, Bruckner-Tuderman L, August C et al. Compound heterozygosity for missense (L156P): and nonsense. (R554X): mutations in the β4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia. Am J Pathol; 1998; 152: 935-41.
29. Mellerio JE, Pulkkinen L, McMillan JR et al. Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin β4 gene (ITGB4) in two unrelated cases with mild disease. Br J Dermatol, 1998; 139: 862-71.
30. Guo L, Degenstein L, Dowling J et al. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995; 81: 233-43.
31. Christiano AM, Ryynänen M, Uitto J. Dominant dystrophic epidermolysis bullosa: identification of a glycine-to-serine substitution in the triple-helical domain of type VII collagen. Proc Natl Acad Sci (USA) 1994; 91: 3549-53.
32. Cserhalmi-Friedman PB, Karpati S, Horvath A et al. Identification of a glycine-to-arginine substitution G2043R: in a family with dominant dystrophic epidermolysis bullosa from Hungary. Exp Dermatol; 1997; 6: 303-7.
33. Kon A, Nomura K, Pulkkinen L et al. Novel glycine substitution mutations in COL7A1 reveal that the Pasini and Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic. J Invest Dermatol 1997; 109: 684-7.
34. Sakuntabhai A, Hammami-Hauasli N, Rodemer C et al. Deletions within COL7A1 exons distant from consensus splice sites alter splicing and p roduce shortened polypeptide in dominant dystrophic epidermolysis bullosa. Am J Hum Genet 1998; 63: 737-48.
35. Cserhalmi-Friedman PB, McGrath JA, Mellerio JE et al. Restoration of open reading frame due to skipping of an exon with an internal deletion in the COL7A1 gene. Lab Invest 1998; 78: 1483-92.
36. Hilal L, Rochat A, Duquesnoy P et al. A homozygous frameshift mutation in COL7A1 predicting a shortened protein in the generalized mutilating (Hallopeau-Siemens) form of recessive dystrophic epidermolysis bullosa. Nature Genet 1993; 5: 160-8.
37. Hovnanian A, Hilal L, Blanchet-Bardon C et al. DNA-based prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa in six pregnancies at risk of recurrence. J Invest Dermatol 1995; 104: 456-61.
38. Christiano AM, Greenspan DS, Hoffman GG et al. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nature Genet 1993; 4: 62-6.
39. Dunnill MGS, McGrath JA, Richards AJ et al. Clinico-pathological correlations of compound heterozygous COL7A1 mutations in three unrelated patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996; 107: 171-7.
40. Hovnanian A, Rochet A, Bodemer C et al. Characterisation of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am J Hum Genet 1997; 61: 599-610.
41. Lee JY-Y, Pulkkinen L, Liu H-S et al. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa. J Invest Dermatol 1997; 108: 947-9.
42. Christiano AM, Bart B, Epstein EH et al. Genetic basis of Bart's syndrome: a glycine substitution in the type VII collagen gene. J Invest Dermatol 1996; 106: 778-80.
43. Christiano AM, Fine J-D, Uitto J. Genetic basis of dominantly inherited transient bullous dermolysis of the newborn: a splice site mutation in the type VII collagen gene. J Invest Dermatol 1997; 109: 811-4.
44. McGrath JA, Handyside AH. Preimplantation genetic diagnosis of severe inherited skin diseases. Exp Dermatol 1998: 7: 65-72.
45. Khavari PA, Krueger GG. Cutaneous gene therapy. Dermatol Clin 1997; 15: 27-35.